MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 8, 2006; DOI: 10.1124/mol.105.021923


0026-895X/06/7003-860-868$20.00
Mol Pharmacol 70:860-868, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.021923v1
70/3/860    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Filtz, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Filtz, T. M.

Phospholipase C-beta3 and -beta1 Form Homodimers, but Not Heterodimers, through Catalytic and Carboxyl-Terminal Domains

Yong Zhang, Walter K. Vogel, Jennifer S. McCullar, Jeffrey A. Greenwood, and Theresa M. Filtz

Department of Pharmaceutical Sciences, College of Pharmacy (W.K.V., T.M.F.), Department of Biochemistry and Biophysics (J.A.G., T.M.F.), and the Molecular and Cellular Biology Program (Y.Z., J.S.M., T.M.F.), Oregon State University, Corvallis, Oregon

Phospholipase C-beta (PLC-beta) isoenzymes are key effectors in G protein-coupled signaling pathways. Prior research suggests that some isoforms of PLC-beta may exist and function as dimers. Using coimmunoprecipitation assays of differentially tagged PLC-beta constructs and size-exclusion chromatography of native PLC-beta, we observed homodimerization of PLC-beta3 and PLC-beta1 isoenzymes but failed to detect heterodimerization of these isoenzymes. Size-exclusion chromatography data suggest that PLC-beta3 and PLC-beta1 form higher affinity homodimers than PLC-beta2. Evidence supportive of limited PLC-beta monomer-homodimer equilibrium appears at ≤100 nM. Further assessment of homodimerization status by coimmunoprecipitation assays with differentially tagged PLC-beta3 fragments demonstrated that at least two subdomains of PLC-beta3 are involved in dimer formation, one in the catalytic X and Y domains and the other in the G protein-regulated carboxyl-terminal domain. In addition, we provide evidence consistent with the existence of PLC-beta homodimers in a whole-cell context, using fluorescent protein-tagged constructs and microscopic fluorescence resonance energy transfer assays.


Received December 28, 2005; accepted June 8, 2006

Address correspondence to: Theresa M. Filtz, 203 Pharmacy Building, Oregon State University, Corvallis, OR 97331-3507. E-mail: theresa.filtz{at}oregonstate.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Shao, X. Shi, H. Wehbi, C. Zambonelli, J. F. Head, B. A. Seaton, and M. F. Roberts
Dimer Structure of an Interfacially Impaired Phosphatidylinositol-specific Phospholipase C
J. Biol. Chem., March 23, 2007; 282(12): 9228 - 9235.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics